BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join

  Latest News

Pusan National University Researchers Develop AI Model to Identify Therapeutic Gene Targets Using Hypergraphs

by BiopharmaTrend   •   March 7, 2025    - updated on May 26, 2025

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

# Tools & Methods   
Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email

A team from Pusan National University, led by Associate Professor Giltae Song, has developed a new artificial intelligence model called the Hypergraph Interaction Transformer (HIT) to improve the identification of therapeutic gene targets. 

The research was published in Briefings in Bioinformatics (January 2025, Vol. 26, Issue 1).

#advertisement
AI in Drug Discovery Report 2025

Unlike conventional deep learning models that struggle to capture the complex many-to-many relationships between diseases, genes, and ontologies, HIT uses hypergraph structures and attention-based encoders to represent these associations more effectively. The model constructs separate gene and disease hypergraphs from biological datasets and processes them using a two-stage encoding system to classify genes as therapeutic targets, biomarkers, or unrelated.

In benchmark testing, HIT outperformed all existing models across evaluation metrics and required only 1 hour and 40 minutes of GPU-based training and inference time. A case study on heart failure showed the model successfully identified all known therapeutic targets. The researchers emphasize HIT’s explainability as a key feature, enabling transparency in how gene-disease associations are determined—critical for clinical and translational research.

The model is intended to shorten the drug development pipeline and enhance the precision of early-stage therapeutic research, particularly in the context of personalized medicine.

Topics: Tools & Methods   

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.